DIA

20 data points extracted from 1 publication by this organisation.

Data points
20
Documents
1
Indicators
20
Regions
1
Publisher type
Industry association

Bibliography

Documents used

Every publication we have taken a number from, with the date we read it and the link status at that time.

Document Type Published Retrieved Link Data points
2025 NMPA Approvals: China Clears Record Number of New Drugs Licence: See source Press release 17 Sep 2026 Reachable 20

Every figure

Data points

Every figure taken from this organisation, grouped by indicator.

20 data points across 20 indicators.
IndicatorRegionPeriodValueTypeFull record
Antibody-drug conjugate approvalsChina20253actual
Biologic therapy approvalsChina202540actual
Bispecific antibody approvalsChina20254actual
Breast cancer drug approvalsChina20259actual
Cell therapy approvalsChina20253actual
Conventional medicine approvalsChina202580actual
Domestic contribution to new entrant increaseChina202581%actual
Domestic developer drug approvalsChina202563actual
Domestic developer share of drug approvalsChina202552%actual
First global drug approvalsChina202561actual
Fusion protein approvalsChina20253actual
Imported drug approvalsChina202557actual
Imported drug share of approvalsChina202548%actual
Monoclonal antibody approvalsChina202518actual
Monoclonal antibody share of new drug approvalsChina202515%actual
New drug approvalsChina2025120actual
Peptide therapy approvalsChina20254actual
Small molecule drug approvalsChina202572actual
Small molecule share of new drug approvalsChina202560%actual
Type 2 diabetes drug launchesChina20256actual

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. Credit DIA as the original publisher; each record page carries its own citation.

DIA. Retrieved from StatOrigin: https://statorigin.org/sources/dia

Keep exploring

Related

Last verified 17 September 2026. Link status is rechecked weekly.